# Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease

> **NCT02055222** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 7 (actual)

## Conditions studied

- Pulmonary Fibrosis
- Lung Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02055222
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-14
- **Primary completion:** 2018-01-01
- **Final completion:** 2018-08-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055222, "Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02055222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*